68Ga-NODAGA-E[c(RGDyK)]2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NODAGA-E[c(RGDyK)]2, covering 2022-06-30 to 2022-06-30. Get the full timeline:
Most recent: Clinical Trial Update: PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2 [Phase 2]